Contact: Chris Hillios
P.O. Box 90
Southampton, MA 01073
Phone: 413-527-4059
info@confidisc.com http://www.confidisc.com
USPTO Awards Key Patent for New Syringe Injection System, ConfiDisc®.
SOUTHAMPTON, MA, September 14, 2010 - Product innovators, Chris and Sonia Hillios, are pleased to announce that they have been granted a patent by the U.S. Patent and Trademark Office pertaining to their new syringe injection system, ConfiDisc®
The patent covers the innovator’s syringe injection system, which enables users to achieve the correct angle and depth of subcutaneous and intramuscular injections. The ConfiDisc® Syringe Injection System was developed for insulin and like medications and can be utilized in both home healthcare and professional medical settings. ConfiDisc® is an aid for injecting by syringe or pen needle. It provides added stability in both filling the syringe and during injection. ConfiDisc® has many benefits. It reduces pain perception and injection anxiety. Confidisc® enables users access to a larger range of injection sites, allowing better injection rotation. As a new hypodermic syringe, ConfiDisc® can greatly deter illegal intravenous drug use as it prevents injecting into a vein or artery.
This patent rewards the innovator’s efforts to bring new technologies to the healthcare market. It grants ConfiDisc® intellectual property to the core functionality of it’s syringe injection system. The patent provides further security to ConfiDisc’s® embodiments which are recognized by the Federal Government.
There are more than 22 million diabetics in the United States alone. This makes up more than 7% of the U.S. population. Two-thirds of “at home” injections are self-administered. Injection anxiety is a proven cause of treatment failure, which leads to serious and life threatening complications. “We believe that our syringe injection system will greatly benefit all patients requiring daily injections. ConfiDisc® provides users the confidence they need and the comfort they deserve. ConfiDisc® is the next generation of syringe” said product developer, Chris Hillios.
“ConfiDisc®” is a registered trademark of Chris and Sonia Hillios.
###
FOR IMMEDIATE RELEASE
Contact: Chris Hillios
P.O. Box 535
Southampton, MA 01073
Phone: 413-527-4059
http://www.confidisc.com info@confidisc.com
Diabetic Innovator Announces New Injection Aid
Southampton, MA – September 4, 2007 – When faced with the certainty of daily insulin injections, innovator Chris Hillios knew he had to design a device that would help him overcome his injection anxiety. Through his determination and innovative spirit, Confidisc® was developed.
Confidisc® is an aid for injecting by syringe or pen, insulin or like medications.
It can be used by the patient or by a caregiver. “It is truly amazing that a simple device like Confidisc® can make such a huge difference in one’s life. Our testing has shown that Confidisc® not only reduced pain perception, it clearly reduced injection anxiety.” said Chris Hillios. “Users focus on the disk rather than the needle.” With Confidisc’s® help, patient’s lab results are now better than ever.
Confidisc® enables users access to a larger range of injection sites, allowing better injection rotation. It provides added stability in both filling the syringe and during injection. Its simple form is easy to use, convenient and cost effective. Confidisc® may be manufactured as a reusable attachment product and/or as a permanently fixed part of a hypodermic syringe. As a new hypodermic syringe, Confidisc® also helps to deter illegal intravenous drug use.
More than 18 million Americans are living with type 2 diabetes. Many suffer from injection anxiety. Fear of injection can lead to improper treatment and poor control. “Having first hand knowledge of the problems associated with home injections, it is our belief that this product will be of enormous benefit to the ever-growing diabetic population. Confidisc® provides the confidence I need. I will no longer inject without it.” said Chris Hillios.
Confidisc® was well received by a review of Endocrinologist, Diabetic Educators and Nurse Practitioners. They look forward to having it available for their patients. It is sure to be a beneficial, simple, and affordable product for everyone facing daily injections. “Diabetes was our primary concern. However, we can now see that as the self injectable market grows, the uses for Confidisc® also grows.”
PHOTOS AVAILABLE
###
News Article Two
STRANGE NEW PRODUCTS.COM
Confidisc Makes Hypodermic Injections Easier by Steve
Thursday, November 01, 2007
The Confidisc is a plastic disk that fits over the needle of a hypodermic syringe, blocking one's view of the needle. The manufacturer says that this reduces the pain perception associated with self-administered injections.
Confidisc
It was created by a diabetic named Chris Hillios who had faced fears of injecting himself with insulin. By focusing on the disk rather than the needle, he claims it makes self-administered injections so much more easier...
It is truly amazing that a simple device like Confidisc can make such a huge difference in one's life. Our testing has shown that Confidisc not only reduced pain perception, it clearly reduced injection anxiety.
He also says that the disk forces the needle into the skin at a 90 degree angle, and promotes proper use.
He offers two types, one is a disc that fits over a syringe, and the other is a syringe with the disk molded on, to prevent intravenous drug use.
Learn more about Confidisc at...
http://www.confidisc.com/
Inventor’s injection device relieves the anticipated pain of shots By Marc Songini
A local device inventor is trying to take the sting out of the task of performing repeated injections.
The original syringe was invented in 1853 and has largely been left unchanged, noted Chris Hillios, a retired inventor who said he has improved on the concept with his Confidisc platform. He said the traditional syringe’s design is highly limited, and created with the health care professional in mind. People who need repeated injections find the process unpleasant, difficult and intimidating. When injecting, the patient will often become nervous when looking at the needle, causing hesitation and errors. Confidisc hides the needle and lets the patient focus properly.
“There is a huge amount of people suffering from injection anxiety,” said Hillios, himself a diabetic. “Some people would rather lose a leg or go blind rather than inject themselves,” he said. “I put it off six years.”
To aid in the filling of the syringe and ease the anxiety of injection, he created a medical device prototype called Confidisc. The Confidisc is essentially a polymer-based disk 1.25 inches in diameter that can fit onto a syringe and act as a stable base on the skin to make it easier to inject, said Hillios. It can be manufactured as an attachment product for a syringe or pen, or as a new hypodermic syringe.
Hillios has funded the development of Confidisc himself and isn’t interested in launching a company. Rather, he’d like to have an investor and partner do that, and make back what he’s spent so far.
The potential market could include the 20 millon or so diabetics in the United States. Some syringe makers already sell devices to assist in injection, such as spring-loaded needles, but these cost as much as $49 and are cumbersome and “very intimidating.” The Confidisc is designed to be simple and would cost only about a dollar. “This simple, cost-effective, no-brainer type of thing should have been done years ago,” Hillios said.
While nothing can really take away injection anxiety, such a device can go quite a ways to at least assisting those who are not medical professionals in performing the injections more precisely, noted Tom Tracy, surgeon-in-chief at Hasbro Children’s Hospital in Providence, R.I.
Chris Hillios realized that he had injection anxiety and set out to design a device that would help him overcome that fear. He succeeded and the result is the Confidisc.
A simple little disk that is added to the end of the syringe or needle that blocks the view of the needle point and allows the patient to focus on the disk rather than the needle.
Another added benefit is that its design virtually eliminates the possibility of inserting the needle intravenously because its design promotes a 90 degree injection angle.
The Confidisc also allows a larger range of injection sites and thereby allows better injection site rotation making it easier for patient or caregiver to inject in hard to reach places.
Confidisc is a simple, yet effective, gadget that is used as an aid when injecting insulin or other medication by syringe or pen. "It is truly amazing that a simple device like Confidisc can make such a huge difference in one's life. Our testing has shown that Confidisc not only reduced pain perception, it clearly reduced injection anxiety," said Chris Hillios. "Users focus on the disk rather than the needle." Confidisc™ was well received by a review of Endocrinologist, Diabetic Educators and Nurse Practitioners. They look forward to having it available for their patients. It is sure to be a beneficial, simple, and affordable product for everyone facing daily injections. Diabetes was our primary concern. However, we can now see that as the self injectable market grows, the uses for Confidisc™ also grows.
November 1, 2007